Suicide in European Hodgkin Lymphoma Patients

Por Kim, Austin I., Goergen, Helen, Engert, Andreas, LaCasce, Ann S., Maranda, Louise, Barton, Bruce, Borchmann, Sven
Publicado no Hemasphere (2019)

The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered

Por Borchmann, Peter, Fosså, Alexander, Długosz-Danecka, Monika, Böll, Boris, Dietlein, Markus, Kobe, Carsten, Goergen, Helen, Engert, Andreas
Publicado no Hemasphere (2018)

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

Por Momotow, Jesko, Goergen, Helen, Behringer, Karolin, Bröckelmann, Paul J., Borchmann, Sven, Tresckow, Bastian v., Kobe, Carsten, Engert, Andreas, Sasse, Stephanie
Publicado no Hemasphere (2019)

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgk...

Por Engert, Andreas, Goergen, Helen, Markova, Jana, Pabst, Thomas, Meissner, Julia, Zijlstra, Josée M., Král, Zdenek, Eichenauer, Dennis A., Soekler, Martin, Greil, Richard, Kreissl, Stefanie, Scheuvens, Ruth, Eich, Hans, Kobe, Carsten, Dietlein, Markus, Stein, Harald, Fuchs, Michael, Diehl, Volker, Borchmann, Peter
Publicado no Hemasphere (2017)